These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21730234)

  • 1. Myocardial enzyme levels and mortality after coronary artery bypass graft surgery.
    Algarni KD
    JAMA; 2011 Jul; 306(1):39-40; author reply 40. PubMed ID: 21730234
    [No Abstract]   [Full Text] [Related]  

  • 2. Myocardial enzyme levels and mortality after coronary artery bypass graft surgery.
    Conti VR; Riall TS; Sheffield KM
    JAMA; 2011 Jul; 306(1):39; author reply 40. PubMed ID: 21730235
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery.
    Domanski MJ; Mahaffey K; Hasselblad V; Brener SJ; Smith PK; Hillis G; Engoren M; Alexander JH; Levy JH; Chaitman BR; Broderick S; Mack MJ; Pieper KS; Farkouh ME
    JAMA; 2011 Feb; 305(6):585-91. PubMed ID: 21304084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Troponin T is a better predictor than creatine kinase-MB of long-term mortality after coronary artery bypass graft surgery.
    Søraas CL; Friis C; Engebretsen KV; Sandvik L; Kjeldsen SE; Tønnessen T
    Am Heart J; 2012 Nov; 164(5):779-85. PubMed ID: 23137510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do we really need another biomarker to diagnose myocardial infarction after coronary artery bypass graft surgery?
    Rade JJ; Hogue CW
    Anesth Analg; 2010 Nov; 111(5):1086-7. PubMed ID: 20971957
    [No Abstract]   [Full Text] [Related]  

  • 6. Biochemical injury markers and mortality after coronary artery bypass grafting: a systematic review.
    Petäjä L; Salmenperä M; Pulkki K; Pettilä V
    Ann Thorac Surg; 2009 Jun; 87(6):1981-92. PubMed ID: 19463650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative white blood cell count is independently associated with higher perioperative cardiac enzyme release and increased 1-year mortality after coronary artery bypass grafting.
    Newall N; Grayson AD; Oo AY; Palmer ND; Dihmis WC; Rashid A; Stables RH
    Ann Thorac Surg; 2006 Feb; 81(2):583-9. PubMed ID: 16427856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial enzyme release in totally endoscopic coronary artery bypass grafting on the arrested heart.
    Schachner T; Bonaros N; Ruetzler E; Weidinger F; Oehlinger A; Laufer G; Friedrich G; Bonatti J
    J Thorac Cardiovasc Surg; 2007 Oct; 134(4):1006-11. PubMed ID: 17903521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cardiopulmonary bypass on tissue injury markers and endothelial activation during coronary artery bypass graft surgery.
    Nair S; Iqbal K; Phadke M; Jadhav UE; Khandekar J; Khandeparkar JM
    J Postgrad Med; 2012; 58(1):8-13. PubMed ID: 22387642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Type 4a myocardial infarction].
    Mironova OIu
    Ter Arkh; 2014; 86(9):102-7. PubMed ID: 25518514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial injury in coronary artery bypass grafting: on-pump versus off-pump comparison by measuring high-sensitivity C-reactive protein, cardiac troponin I, heart-type fatty acid-binding protein, creatine kinase-MB, and myoglobin release.
    Chowdhury UK; Malik V; Yadav R; Seth S; Ramakrishnan L; Kalaivani M; Reddy SM; Subramaniam GK; Govindappa R; Kakani M
    J Thorac Cardiovasc Surg; 2008 May; 135(5):1110-9, 1119.e1-10. PubMed ID: 18455592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing the diagnosis of acute myocardial infarction: implications for practice and clinical investigations.
    Newby LK; Alpert JS; Ohman EM; Thygesen K; Califf RM
    Am Heart J; 2002 Dec; 144(6):957-80. PubMed ID: 12486420
    [No Abstract]   [Full Text] [Related]  

  • 13. Incidence, correlates, and significance of abnormal cardiac enzyme rises in patients treated with surgical or percutaneous based revascularisation: a substudy from the Synergy between Percutaneous Coronary Interventions with Taxus and Cardiac Surgery (SYNTAX) Trial.
    Farooq V; Serruys PW; Vranckx P; Bourantas CV; Girasis C; Holmes DR; Kappetein AP; Mack M; Feldman T; Morice MC; Colombo A; Morel MA; de Vries T; Dawkins KD; Mohr FW; James S; Ståhle E
    Int J Cardiol; 2013 Oct; 168(6):5287-92. PubMed ID: 23993326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI).
    Moussa ID; Klein LW; Shah B; Mehran R; Mack MJ; Brilakis ES; Reilly JP; Zoghbi G; Holper E; Stone GW;
    Catheter Cardiovasc Interv; 2014 Jan; 83(1):27-36. PubMed ID: 23894025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of elevated creatine kinase-myocardial band on mortality after coronary artery bypass grafting surgery is time and magnitude limited.
    Engoren MC; Habib RH; Zacharias A; Schwann TA; Riordan CJ; Durham SJ; Shah A
    Eur J Cardiothorac Surg; 2005 Jul; 28(1):114-9. PubMed ID: 15982595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implications of troponin T and creatine kinase-MB elevation after coronary artery bypass grafting.
    Domanski MJ
    Am Heart J; 2012 Nov; 164(5):636-7. PubMed ID: 23137492
    [No Abstract]   [Full Text] [Related]  

  • 17. With the "universal definition," measurement of creatine kinase-myocardial band rather than troponin allows more accurate diagnosis of periprocedural necrosis and infarction after coronary intervention.
    Lim CC; van Gaal WJ; Testa L; Cuculi F; Arnold JR; Karamitsos T; Francis JM; Petersen SE; Digby JE; Westaby S; Antoniades C; Kharbanda RK; Burrell LM; Neubauer S; Banning AP
    J Am Coll Cardiol; 2011 Feb; 57(6):653-61. PubMed ID: 21292125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher levels of serum cytokines and myocardial tissue markers during on-pump versus off-pump coronary artery bypass surgery.
    Nesher N; Frolkis I; Vardi M; Sheinberg N; Bakir I; Caselman F; Pevni D; Ben-Gal Y; Sharony R; Bolotin G; Loberman D; Uretzky G; Weinbroum AA
    J Card Surg; 2006; 21(4):395-402. PubMed ID: 16846420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term prognostic value of cardiac troponin I and T versus creatine kinase-MB mass after cardiac surgery in low-risk patients with stable symptoms.
    Vikenes K; Andersen KS; Melberg T; Farstad M; Nordrehaug JE
    Am J Cardiol; 2010 Sep; 106(6):780-6. PubMed ID: 20816117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac troponin I and creatine kinase-MB release after different cardiac surgeries.
    Mastro F; Guida P; Scrascia G; Rotunno C; Amorese L; Carrozzo A; Capone G; Paparella D
    J Cardiovasc Med (Hagerstown); 2015 Jun; 16(6):456-64. PubMed ID: 25022928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.